Science AI Journal
Medicine · Research topic

Open research questions in Pain Management and Treatment

41 unresolved questions extracted from the limitations and future-work sections of 270 Pain Management and Treatment papers in our library. Each links back to the study that raised it.

What the literature leaves open

  • Interpre- tation of our MME data is limited by the high proportion of opioid- naïve patients at baseline, including 80 patients with pre- MME of 0 and 10 patients with missing pre- MME, which creates a floor effect that constrains detection of any opioid- sparing signal.

    Longitudinal outcomes following temporary 60-day percutaneous peripheral nerve stimulation for chronic pain: a retrospective analysis · 2026 · DOI

  • BACKGROUND Complex regional pain syndrome (CRPS) most commonly affects distal extremities; atypical truncal presentations may be underrecognized and can mimic cardiopulmonary pathology.

    Spinal cord stimulation for atypical anterior chest wall complex regional pain syndrome: illustrative case · 2026 · DOI

  • Future research should focus on identifying predictors of treatment response, optimizing stimulation parameters, involving neurostimulation, evaluating long-term effectiveness, and exploring combination strategies 844 pharmacotherapy, psychotherapy, rehabilitation, and behavioral interventions. Additionally, long-term outcome data remain limited for certain emerging technologies, particularly within rapidly evolving areas such as adaptive neuromodulation and advanced brain stimulation systems.

    Advances in Neurostimulation for Treatment-Resistant Depression and Chronic Pain: Emerging Neuromodulation Strategies in Modern Clinical Neuroscience · 2026 · DOI

  • Supervised SLS met key safety, tolerability, and feasibility criteria, and a lower visual-phenomenology active control can be carried forward, while masking and comparator credibility remain to be established.

    Stroboscopic Light Stimulation in Adults Reporting Depressive Symptoms: Safety, Tolerability, Feasibility, and Active-Comparator Development in a Staged Early-Phase Study · 2026 · DOI

  • Spinal cord stimulation (SCS) is an established neuromodulation modality for neuropathic pain management and peripheral nerve functional repair, yet clinical evidence supporting SCS for COVID-19-associated multiple peripheral neuropathy remains scarce, especially in patients with mild COVID-19 lacking mechanical nerve compression risk factors.

    Stimulation Successfully Relieved COVID-19-induced Peripheral Nerve Injury in Left Limbs: A Case Report · 2026 · DOI

  • Importance Preoperative antibiotics are currently recommended before sacral neuromodulation (SNM), but no guidelines exist for postoperative prophylaxis.

    Cost-Effectiveness of Antibiotics in Sacral Neuromodulation · 2026 · DOI

  • Although important results presented in the current study, it should be interpreted in light of several limita- tions. First, the sample size was insufficient to support the potential of generalizing the results. Second, gener- alization is limited by the relatively homogeneous study population, which was mostly composed of residents of Sohag Governorate and for which all data were gath- ered at Sohag University Hospital. Third, the variations in the methods employed to investigate the H-reflex and the interrater variation in the findings across different research. The painful procedures used discouraged more female controls to participate in the study which made a sample bias that could affect the results we found.

    Neurophysiological assessment of spinal excitability in chronic low back pain: a case-control study · 2026 · DOI

  • To our knowledge, this is the most comprehensive meta- analysis evaluating opioid use outcomes following SCS implantation among patients with chronic pain. Additionally, our study is compliant with methodological guidelines including PRISMA,28 MOOSE,41 and guidelines specifically designed for conducting systematic reviews and meta- analyses in pain medicine.60 61 Several limitations should be considered when interpreting the results of this study. First, the predominance of observational studies and the substantial heterogeneity of studies lower the certainty of evidence and warrant great caution when inter- preting the results of this study. Second, some analyses were limited to only two to four studies and there were small sample sizes for some of the subgroup analyses (ie, stimulation wave- forms) which yielded wide CIs and limited interpretability. Third, the inability to quantify possible placebo effects or psychological dependence on opioids likely influences outcomes. Fourth, as noted above, some physicians and countries require intentional opioid tapering prior to SCS implantation. While there is not strong evidence to suggest this strongly influenced our results one way or another, it is possible that opioid use could be overes- timated or underestimated depending on the intentional opioid tapering circumstances. Lastly, there likely exist significant vari- ances in opioid tapering protocols and practices following SCS implantation that were not adjusted for in our analyses.

    Change in opioid use following spinal cord stimulation: a systematic review and meta-analysis · 2026 · DOI

  • The certainty of our results is limited due to the inclusion of observational studies and heterogeneity in study outcomes. Prospective, well- powered RCTs studying standardized opioid outcome measures are needed to confirm these findings and elevate the quality of evidence. Future studies should also strive to identify patient- level predictors of opioid reduction success, to conduct comparisons of SCS stimulation waveforms, and to incorporate functional and quality of life metrics to fully charac- terize additional benefits of SCS therapy. Lastly, future RCTs and meta- analyses evaluating relative change in opioid use among SCS and control groups would also be helpful for a better under- standing of SCS- related outcomes.

    Change in opioid use following spinal cord stimulation: a systematic review and meta-analysis · 2026 · DOI

  • The future of spinal cord stimulation (SCS) is increasingly being shaped by the vision of integrated, intelligent neuromodulation ecosystems—systems capable of seamless communication across spinal, cortical, and peripheral neural networks. These next- generation platforms are envisioned not merely as isolated stimulators but as interconnected systems that continuously interpret, adapt, and respond to the dynamic complexity of human neurophysiology. By enabling cross-talk between multiple neural domains, SCS may evolve into a truly holistic therapeutic approach that bridges the divide between pain modulation, motor restoration, and cognitive regulation. Emerging technological frontiers are expanding the scope of this vision. Biofeedback data gathered from wearable sensors can capture real-time physiological and behavioral metrics, such as heart rate variability, muscle activation, and posture. When processed through cloud- based data analytics frameworks, these signals provide actionable insights into each patient’s response patterns, allowing SCS devices to adjust stimulation parameters autonomously and precisely. Moreover, advances in biological interfacing technologies—including optogenetics and bioelectronic medicine—offer exciting possibilities for achieving finer spatial and temporal control over neural circuits. These innovations could enable stimulation that is not only personalized but also biologically harmonious, tailoring neural modulation to the patient’s intrinsic rhythms and synaptic connectivity. Clinical consensus now strongly supports a forward-looking strategy centered on individualized therapy design. Guidelines emphasize the importance of customizing stimulation waveforms, developing multidisciplinary care teams, and maintaining structured long-term follow-up programs to ensure consistent patient benefit and safety. Collaborative clinical frameworks that integrate pain specialists, neuroscientists, engineers, and data scientists are likely to become increasingly essential for optimizing outcomes and sustaining innovation.[17] As SCS enters this next stage of development, its evolution from a static device therapy to a dynamic, networked neurotherapeutic platform will redefine standards in pain management and neurological rehabilitation. The integration of adaptive feedback, predictive analytics, www.wjpps.com │ Vol 15, Issue 4, 2026. │ ISO 9001:2015 Certified Journal │ 59 Sushma et al. World Journal of Pharmacy and Pharmaceutical Sciences and bioresponsive stimulation embodies the future promise of precision neuromodulation— an intelligent, empathetic, and patient-centered dimension of care poised to transform how chronic pain and neural disorders are understood and treated.

    NEUROMODULATION REVOLUTION: HOW EMERGING SPINAL CORD STIMULATION DEVICES ARE TRANSFORMING PAIN AND NEUROLOGICAL CARE · 2026 · DOI

  • Treatment options include antidepressants, gamma-aminobutyric acid (GABA) analogs, opioids, and topical analgesics, which are intended to alleviate pain and symptoms of neuropathy, but limited data are available on their efficacy.

    Treatment of painful polyneuropathies of diabetic and other origins with 10 kHz SCS: a case series · 2020 · DOI

  • However, the use of QST outside the lab has been limited by several factors, including a lack of standardization, variability in procedural technique, and duration of testing that would be unacceptable for clinic.

    Outsiders Looking in? Ensuring that Teachers of the Gifted and Talented Education and Teachers of Students with Disabilities Are Part of the "In-Crowd". · 2010 · DOI

  • Previous studies that have examined the effects of TENS upon the RIII nociceptive reflex have used a diversity of methodologies and provided equivocal results.

    A Review of the Effects of Transcutaneous Electrical Nerve Stimulation upon the RIII Nociceptive Reflex · 2000 · DOI

  • Although research in this field has expanded substantially, its global research landscape, knowledge structure, and emerging trends have not been systematically evaluated.

    Research trends of transcutaneous electrical nerve stimulation in pain management from 2015 to 2024: A bibliometric and visualization analysis · 2026 · DOI

  • Ultimately, further exploration into the specific mechanisms by which neuromodulation impacts mitochondrial health and function in neuropathies is warranted.

    The effects of pulsed radiofrequency stimulation on mitochondrial function in neurons: a mini review · 2026 · DOI

  • Usually, the prescription of opioid analgesics is required, but there is no data on their effectiveness in the comprehensive therapy of phantom pain, which appears as a result of limb amputation and is one of the most difficult clinical problems today.

    Features of opioid analgesia s in patients with phantom limb pain after amputation due to gunshot wounds · 2023 · DOI

  • There is a great deal of tools for treatment of occipital neuralgia but currently we are lacking a complete consensus among practitioners regarding the optimal approach to this debilitating condition.

    Effectiveness of treatment of occipital neuralgia using the nerve block technique: a prospective analysis of 44 patients · 2018 · DOI

  • Currently, there is insufficient robust evidence to support the use of sclerosing injections in the treatment of painful tendinopathy with concomitant neovascularity.

    The efficacy of sclerosing injections in the treatment of painful tendinopathy · 2011 · DOI

  • This paper outlines the work to date, highlights the clinical implications of this work as well as possible reasons for the equivocal results and suggests areas for future investigations.

    A Review of the Effects of Transcutaneous Electrical Nerve Stimulation upon the RIII Nociceptive Reflex · 2000 · DOI

  • Although the characteristics and time course of phantom limb pain are well described in the literature, no single theoretical approach can fully account for the contradictory aspects of this condition, thus its underlying mechanisms remain unclear.

    Phantom Limb Pain. A Review · 1988 · DOI

Most-cited papers in Pain Management and Treatment

Most recent work

Find a gap in your own Pain Management and Treatment sub-topic

This page shows what the Pain Management and Treatment literature already flags as unresolved. To narrow it to your specific question, run the guided finder — it searches the gap library on demand and checks candidates against 250M+ OpenAlex works.

Open the Research Gap Finder →

Related topics in Medicine

Substance Abuse Treatment and Outcomes
989 open questions
Artificial Intelligence in Healthcare and Education
607 open questions
Attention Deficit Hyperactivity Disorder
448 open questions
Physical Activity and Health
436 open questions
Smoking Behavior and Cessation
402 open questions
Innovations in Medical Education
364 open questions
Dementia and Cognitive Impairment Research
363 open questions
HIV/AIDS Research and Interventions
342 open questions
41 open questions have been extracted from the limitations and future-work passages of 270 Pain Management and Treatment papers in our library. Each one below links back to the study that raised it, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 120,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? A Tier 1–5 acceptance probability in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck prior-publication & salami-slicing risk across 8 sources.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.